AB

Amita Balwant Shirke

Active Director Director DIN 09427332
DIN 09427332 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Amita Balwant Shirke

Data last updated:

Amita Balwant Shirke is a Director at Indicellbio India Private Limited (since 2021). The company operates in Chemicals. Indicellbio India Private Limited reported revenue of ₹11.9 Lakh (FY 2024).

DIN 09427332
Primary Designation Director
Industry Chemicals
First Appointment 07 Dec 2021
Oldest Company Age 4 yrs
Largest company Indicellbio India Private Limited · ₹11.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indicellbio India Private Limited U24299TN2021FTC148433
Director07 Dec 20212021₹11.9 Lakh (FY 2024)Active

Board colleagues of Amita Balwant Shirke

NameDINCompanyDesignation
Jong Soo Lee10775981Indicellbio India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indicellbio India Private Limited
Premium access

Shareholding and investment profile for Amita Balwant Shirke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amita Balwant Shirke

Amita Balwant Shirke currently holds 1 directorship: Indicellbio India Private Limited (Director, since 07 Dec 2021, revenue ₹11.9 Lakh (FY 2024)).

Amita Balwant Shirke was first appointed on 07 Dec 2021 as Director at Indicellbio India Private Limited.

The current boards of Amita Balwant Shirke's companies include Jong Soo Lee (Indicellbio India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available